| Record ID | ia:importantinforma00illi |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/importantinforma00illi/importantinforma00illi_marc.xml |
| Download MARC binary | https://www.archive.org/download/importantinforma00illi/importantinforma00illi_meta.mrc |
LEADER: 01253cam 2200289Ia 4500
001 4744202
005 20040520144556.0
008 031125s2003 ilu s000 0 eng d
035 $a(OCoLC)ocm53706238
040 $aSPI$cSPI
043 $an-us-il
092 $a616.44$bIMPO
049 $aUIUU
245 00 $aImportant information on the use of potassium iodide (KI) tablets.
246 30 $aPotassium iodide (KI) tablets
246 30 $aKI tablets
260 $aSpringfield, Ill. :$bIllinois Dept. of Nuclear Safety, Division of Planning and Preparedness,$c[2003]
300 $a1 folded sheet (6 p.) ;$c22 x 28 cm. folded to 22 x 10 cm.
500 $aCaption title.
500 $a"2/03"--Colophon.
520 1 $aKI is a non-prescription drug used to provide a "loading dose" of stable iodine to the thyroid when there is a risk that an individual might be exposed to a potentially harmful quantity of radioactive iodine.
650 0 $aPotassium iodide$xTherapeutic use$zIllinois.
650 0 $aThyroid gland$xDiseases$zIllinois$xPrevention.
650 0 $aIodides$xIsotopes$xToxicology$zIllinois.
650 0 $aRadiation-protective agents$zIllinois.
710 1 $aIllinois.$bDept. of Nuclear Safety.$bDivision of Planning and Preparedness.
994 $aX0$bUIU